Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elobixibat Safety Extension in CIC
NCT01895543Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Sep 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of elobixibat in chronic idiopathic constipation (CIC), sponsored by Ferring Pharmaceuticals. Started Sep 2013; status: completed.
02
Drugs
elobixibat
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT01895543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01895543.